Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06136871
Other study ID # 2096158
Secondary ID R21HD112373-01
Status Recruiting
Phase N/A
First received
Last updated
Start date January 29, 2024
Est. completion date December 2025

Study information

Verified date January 2024
Source University of Missouri-Columbia
Contact Anna E Boone, PhD, OTR/L
Phone 573-882-7023
Email booneae@umsystem.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The first aim of this study is to determine the feasibility of delivering CO-OP remotely to individuals experiencing cognitive impairments that limit everyday activities in post-COVID-19 syndrome (PCS). The second aim of this study is to assess the effect of CO-OP on activity performance, subjective and objective cognition, and quality of life in a sample of individuals with PCS. The research team hypothesizes that effect size estimations will indicate that CO-OP will have a greater positive effect, compared to an inactive control group, on activity performance, subjective and objective cognition, and quality of life in a sample of individuals who self-report PCS and cognitive impairment.


Description:

Post-COVID-19 symptoms (PCS) cognitive symptoms require the rehabilitation community to investigate ways to: (1) reduce the functional impact of the symptoms on daily life and (2) support individuals with PCS to establish new habits to improve and maintain health. While the cognitive impairment associated with PCS has not been well evaluated, it is similar of cognitive symptoms seen in other conditions. Metacognitive strategy training (MCST) approaches are an evidence-based practice standard for improving capacity to self-manage chronic cognitive symptoms and reduce their functional impact on everyday life activities. The CO-OP approach is an MCST intervention in which participants are taught a general cognitive strategy that can be applied in known and novel contexts to devise task specific strategies for engaging in an activity. Existing evidence with other populations suggests that CO-OP has more of a positive effect on improving activity performance and cognition than remediation/retraining-based approaches. These effects have been demonstrated in individuals with mild cognitive impairment that mirrors that found in PCS. The overall research hypothesis is that CO-OP can feasibly be administered remotely and will improve activity performance, subjective and objective cognitive function, and quality of life in individuals with PCS.


Recruitment information / eligibility

Status Recruiting
Enrollment 65
Est. completion date December 2025
Est. primary completion date December 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - self-reported cognitive symptoms persisting for at least 6 weeks following COVID-19 infection (Cognitive Failures Questionnaire (CFQ) score >43) - self-identified activity performance goals per the Canadian Occupational Performance Measure (COPM) - documented prior diagnosis of COVID-19 - read, write, and speak English fluently - ability to provide valid informed electronic consent Exclusion Criteria: - diagnosis of severe neurological or psychiatric condition(s) - dementia symptoms as indicated by a score of <23 on the Montreal Cognitive Assessment (MoCA) - untreated sleep apnea (=5 on the STOPBANG) - prior cancer treatment - severe depressive symptoms (>21 on the Patient Health Questionnaire-9)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
CO-OP Procedures
CO-OP is a metacognitive strategy training intervention that will be used in this study. First, five functional, everyday life goals are identified collaboratively by the participant and interventionist. In the second meeting, we introduce the approach to the subject and teach the global cognitive strategy (i.e., GOAL-PLAN-DO-CHECK). In all subsequent sessions, this strategy is used as the main problem-solving framework to facilitate skill acquisition.The subject identifies a GOAL, and then is guided by the therapist to discover a PLAN to potentially achieve the goal. The subject is then asked to DO the plan (if feasible during the therapy session otherwise asked to complete at home prior to the next treatment session), and subsequently to CHECK to see if the plan worked, i.e. the goal was achieved. This process is repeated until satisfactory performance is met for each established goal.
Inactive Control Group
An inactive control group will be used to control for maturation and testing effects. Weekly contact will be made via teleconferencing to (1) maintain study engagement, (2) introduce weekly social contact with researchers, mimicking some of the potential incidental effects of the experimental group, and (3) ascertain what, if any, additional steps participants have taken to reduce PCS symptoms. The content of each of these meetings will be tracked in intervention notes. Each contact will be recorded for fidelity monitoring to ensure all active ingredients of the CO-OP intervention are avoided.

Locations

Country Name City State
United States University of Missouri Department of Occupational Therapy Columbia Missouri

Sponsors (2)

Lead Sponsor Collaborator
University of Missouri-Columbia Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

References & Publications (6)

Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, Ellmo W, Kalmar K, Giacino JT, Harley JP, Laatsch L, Morse PA, Catanese J. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil. 2005 Aug;86(8):1681-92. doi: 10.1016/j.apmr.2005.03.024. — View Citation

Dawson DR, Anderson ND, Burgess P, Cooper E, Krpan KM, Stuss DT. Further development of the Multiple Errands Test: standardized scoring, reliability, and ecological validity for the Baycrest version. Arch Phys Med Rehabil. 2009 Nov;90(11 Suppl):S41-51. doi: 10.1016/j.apmr.2009.07.012. — View Citation

Geusgens CA, van Heugten CM, Cooijmans JP, Jolles J, van den Heuvel WJ. Transfer effects of a cognitive strategy training for stroke patients with apraxia. J Clin Exp Neuropsychol. 2007 Nov;29(8):831-41. doi: 10.1080/13803390601125971. — View Citation

Haskins EC, Cicerone KD, Trexler LE. Cognitive rehabilitation manual: Translating evidence-based recommendations into practice. ACRM Publishing; 2012.

McEwen S, Polatajko H, Baum C, Rios J, Cirone D, Doherty M, Wolf T. Combined Cognitive-Strategy and Task-Specific Training Improve Transfer to Untrained Activities in Subacute Stroke: An Exploratory Randomized Controlled Trial. Neurorehabil Neural Repair. 2015 Jul;29(6):526-36. doi: 10.1177/1545968314558602. Epub 2014 Nov 21. — View Citation

Wolf TJ, Polatajko H, Baum C, Rios J, Cirone D, Doherty M, McEwen S. Combined Cognitive-Strategy and Task-Specific Training Affects Cognition and Upper-Extremity Function in Subacute Stroke: An Exploratory Randomized Controlled Trial. Am J Occup Ther. 2016 Mar-Apr;70(2):7002290010p1-7002290010p10. doi: 10.5014/ajot.2016.017293. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility measures Recruitment rate, retention rate After study completion, an average of 12 weeks
Primary Telehealth Usability Questionnaire (TUQ) Measure of telehealth usability from participant's perspective. Self-report Likert scale of 1 (disagree) to 7 (agree) After study completion, an average of 12 weeks
Primary Acceptability of Intervention Measure (AIM) Measure of intervention acceptability. Self-report Likert scale of 1 (completely disagree) to 5 (completely agree) After study completion, an average of 12 weeks
Primary Intervention Appropriateness Measure (IAM) Measure of intervention appropriateness. Self-report Likert scale of 1 (completely disagree) to 5 (completely agree) After study completion, an average of 12 weeks
Primary Feasibility of Intervention Measure (FIM) Measure of intervention feasibility. Self-report Likert scale of 1 (completely disagree) to 5 (completely agree) After study completion, an average of 12 weeks
Primary Canadian Occupational Performance Measure (COPM) Self-report measure of activity performance. Minimum = 1, Maximum = 10. Higher scores mean better performance. Pre-intervention (week 0), week 2, week 4, week 6, week 8, and post-intervention (week 12)
Secondary Delis-Kaplan Executive Function System (DKEFS)- Color-Word Interference Objective measure of inhibition and cognitive flexibility. Consists of 4 conditions (color naming, word reading, inhibition, and inhibition/switching). Therapist records client-corrected errors, noncorrected errors, and total time required for each domain. Increased errors and time indicate potential challenges with inhibition and cognitive flexibility. Pre-intervention (week 0) and post-intervention (week 12)
Secondary Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function Self-report measure of cognition. Maximum=5, minimum=1. Higher scores indicate fewer perceived cognitive deficits. Pre-intervention (week 0) and post-intervention (week 12)
Secondary World Health Organization Quality of Life Assessment Instrument (WHOQOL-100) Self-report measure of quality of life. Maximum=5, minimum=1. Higher scores indicate greater perceived quality of life. Pre-intervention (week 0) and post-intervention (week 12)
Secondary Cambridge Neuropsychological Test Automated Battery (CANTAB) Rapid Visual Information Processing Subtest Objective measure of sustained attention. Other outcomes include latency (speed of response), probability of false alarms, and sensitivity. Pre-intervention (week 0) and post-intervention (week 12)
Secondary CANTAB Spatial Working Memory Subtest Objective measure of working memory and strategy. Pre-intervention (week 0) and post-intervention (week 12)
Secondary CANTAB Stockings of Cambridge Subtest Objective measure of planning and executive function. Other outcomes include problem-solving ability and time required to complete task. Pre-intervention (week 0) and post-intervention (week 12)
Secondary CANTAB Delayed Matching to Sample Subtest Objective measure of short-term visual recognition memory and attention. Other outcomes include latency (speed of response), the number of correct patterns selected and a statistical measure giving the probability of an error after a correct or incorrect response. Pre-intervention (week 0) and post-intervention (week 12)
Secondary CANTAB Paired Associates Learning Subtest Objective measure of visual episodic memory. Other outcomes include the errors made by the participant, the number of trials required to locate the pattern(s) correctly, memory scores and stages completed. Pre-intervention (week 0) and post-intervention (week 12)
See also
  Status Clinical Trial Phase
Recruiting NCT06073002 - Effects of a Home-Based Exercise Intervention in Subjects With Long COVID N/A
Completed NCT05047952 - Vortioxetine for Post-COVID-19 Condition Phase 2
Completed NCT05812209 - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Recruiting NCT06091384 - Inspiratory Muscle Strength Training in Post-Covid Syndrome N/A
Not yet recruiting NCT06267300 - Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial Phase 3
Recruiting NCT05986422 - Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS) Phase 2
Not yet recruiting NCT05534997 - Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome N/A
Recruiting NCT05638633 - Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome Phase 3
Active, not recruiting NCT05630040 - VNS for Long-COVID-19 N/A
Recruiting NCT05841498 - Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome N/A
Enrolling by invitation NCT05981872 - EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19 N/A
Active, not recruiting NCT05543408 - Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial" N/A
Recruiting NCT05817032 - Effect of Telerehabilitation Practice in Long COVID-19 Patients N/A
Recruiting NCT05823896 - imPROving Quality of LIFe In the Long COVID Patient Phase 2
Completed NCT05764070 - Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post SARS-CoV-2 Patients N/A
Completed NCT05765591 - Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome N/A
Recruiting NCT05918965 - Vagus Stimulation in Female Long COVID Patients. N/A
Not yet recruiting NCT06231238 - Balance Acceptance and Commitment Therapy for Long COVID Phase 2
Completed NCT06282627 - The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients
Completed NCT05648734 - Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis